SWOG clinical trial number
SWOG-8752

A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer

Closed
Phase
Accrual
17%
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer
Activated
09/15/1988
Closed
07/15/1990